Fatemeh Hadi

Fatemeh Hadi

Auto-generated profile, based on publicly available information

Fatemeh Hadi

Department of Brain and Cognitive Sciences, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2020 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
PDF file
FHFatemeh Hadi
Fatemeh Hadi
HAHassan Akrami
Hassan Akrami
KSKoorosh Shahpasand
Koorosh Shahpasand
MFMohammad R. Fattahi
Mohammad R. Fattahi

24 June 2020 in Therapeutic Delivery
Verified
Journal Article
Closed access
FJFatemeh Jahansooz
Fatemeh Jahansooz
BHBahman Ebrahimi Hosseinzade
Bahman Ebrahimi Hosseinzade
HAHatamian-Zarmi Ashrafalsadat
Hatamian-Zarmi Ashrafalsadat
FHFatemeh Hadi
Fatemeh Hadi
SHSeyed Mohammad Massood Hojjati
Seyed Mohammad Massood Hojjati
KSKoorosh Shahpasand
Koorosh Shahpasand
Aim: Parkinson's disease (PD) is a neurological disorder resulting from decreased dopamine (DA) secretion in the brain, which reflects impaired motor function. Thus, a drug-delivery system for rele... Graphical abstract

1 July 2024 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
FHFatemeh Hadi
Fatemeh Hadi
MMMahsa Mortaja
Mahsa Mortaja
ZHZahra Hadi
Zahra Hadi

2 December 2020 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
FHFatemeh Hadi
Fatemeh Hadi
HAHassan Akrami
Hassan Akrami
MTMehdi Totonchi
Mehdi Totonchi
AFAisan Farhadi
Aisan Farhadi
ABAbdolrazagh Barzegar
Abdolrazagh Barzegar
KSKoorosh Shahpasand
Koorosh Shahpasand

29 October 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AAAmin Ahmadi
Amin Ahmadi
RMReza Moghadasali
Reza Moghadasali
VEVahid Ezzatizadeh
Vahid Ezzatizadeh
ZTZeinab Taghizadeh
Zeinab Taghizadeh
SNSeyed Mahdi Nassiri
Seyed Mahdi Nassiri
NANasser Aghdami
Nasser Aghdami
Injury to podocytes is a principle cause of initiation and progression of both immune and non-immune mediated glomerular diseases that result in proteinuria and decreased function of the kidney. Current advances in regenerative medicine shed light on the therapeutic potential of cell-based strategies for treatment of such disorders. Thus, there is hope that generation and transplantation of podocytes from induced pluripotent stem cells (iPSCs), could potentially be used as a curative treatment for glomerulonephritis caused by podocytes injury and loss. Despite several reports on the generation of iPSC-derived podocytes, there are rare reports about successful use of these cells in animal models. In this study, we first generated a model of anti-podocyte antibody-induced heavy proteinuria that resembled human membranous nephropathy and was characterized by the presence of sub-epithelial immune deposits and podocytes loss. Thereafter, we showed that transplantation of functional iPSC-derived podocytes following podocytes depletion results in recruitment of iPSC-derived podocytes within the damaged glomerulus, and leads to attenuation of proteinuria and histological alterations. These results provided evidence that application of iPSCs-derived renal cells could be a possible therapeutic strategy to favorably influence glomerular diseases outcomes.

5 July 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AAAmin Ahmadi
Amin Ahmadi
RMReza Moghadasali
Reza Moghadasali
VEVahid Ezzatizadeh
Vahid Ezzatizadeh
ZTZeinab Taghizadeh
Zeinab Taghizadeh
SNSeyed Mahdi Nassiri
Seyed Mahdi Nassiri
NANasser Aghdami
Nasser Aghdami